Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage
Public ClinicalTrials.gov record NCT01232400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Adrenergic Blockade After Subarachnoid Hemorrhage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the clinical effect of esmolol treatment on cardiac function and electrophysiology; to assess the effects of esmolol treatment on serum adrenergic and cardiac biomarkers; to explore the safety of esmolol treatment shortly after subarachnoid hemorrhage (SAH). Patients will be followed for a maximum of 1 month after the index SAH. The primary outcome will be change in systolic function - ejection fraction by Simpson's rule (baseline versus Day 7 +/- 2 after SAH).
Study identification
- NCT ID
- NCT01232400
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2014
- Primary completion
- Jun 30, 2015
- Completion
- Jul 31, 2016
- Last update posted
- Jan 7, 2015
2014 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Subarachnoid Hemorrhage trials
Other public records listing Subarachnoid Hemorrhage. Sorted by last update posted; newest first. Not a recommendation.
- NCT03201094: Impact of NMES and HPRO on Recovery After SAH- Pilot Study Recruiting
- NCT05491980: Florida Cerebrovascular Disease Biorepository and Genomics Center Active, not recruiting
- NCT07246629: Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Not yet recruiting
- NCT00593268: Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage Active, not recruiting
- NCT05001750: Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)? Recruiting
- NCT04557618: Auricular VNS Following Subarachnoid Hemorrhage Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01232400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2015 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01232400 live on ClinicalTrials.gov.